Single-session image-guided robotic radiosurgery and quality of life for glomus jugulare tumors.
CyberKnife
glomus jugulare
quality of life
radiosurgery
review
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
13
02
2020
revised:
03
04
2020
accepted:
22
04
2020
pubmed:
13
5
2020
medline:
22
6
2021
entrez:
13
5
2020
Statut:
ppublish
Résumé
Limited data are available on the efficacy and impact on the quality of life (Qol) of single-session image-guided robotic radiosurgery (RRS) for glomus jugulare tumors (GJTs). This study investigates the role of RRS in the management of GJTs and reviews the RRS literature. We analyzed 53 GJT patients treated with RRS to evaluate the safety, local control, clinical outcome, and Qol assessed by the SF12v2. The local control was 98% at a median follow-up of 38 months. The median tumor volume was 4.3 cc and tumors were treated with a median dose of 16.5 Gy. At the last follow-up, 35 patients had recovered from their symptoms or experienced symptom improvement. Qol analyses showed no significant decline while bodily pain significantly decreased. RRS is a safe and efficient tool for the treatment of GJTs. Qol of patients after treatment is stable and tends to improve over time.
Sections du résumé
BACKGROUND
Limited data are available on the efficacy and impact on the quality of life (Qol) of single-session image-guided robotic radiosurgery (RRS) for glomus jugulare tumors (GJTs). This study investigates the role of RRS in the management of GJTs and reviews the RRS literature.
METHODS
We analyzed 53 GJT patients treated with RRS to evaluate the safety, local control, clinical outcome, and Qol assessed by the SF12v2.
RESULTS
The local control was 98% at a median follow-up of 38 months. The median tumor volume was 4.3 cc and tumors were treated with a median dose of 16.5 Gy. At the last follow-up, 35 patients had recovered from their symptoms or experienced symptom improvement. Qol analyses showed no significant decline while bodily pain significantly decreased.
CONCLUSIONS
RRS is a safe and efficient tool for the treatment of GJTs. Qol of patients after treatment is stable and tends to improve over time.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2421-2430Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Welander J, Soderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18(6):R253-R276.
Forbes JA, Brock AA, Ghiassi M, Thompson RC, Haynes DS, Tsai BS. Jugulotympanic paragangliomas: 75 years of evolution in understanding. Neurosurg Focus. 2012;33(2):E13.
Lundgren N. Tympanic body tumours in the middle ear; tumours of carotid body type. Acta Oto-Laryngologica. 1949;37(4):367-379.
Chretien PB, Engelman K, Hoye RC, Geelhoed GW. Surgical management of intravascular glomus jugulare tumor. Am J Surg. 1971;122(6):740-743.
Gulya AJ. The glomus tumor and its biology. Laryngoscope. 1993;103(11 Pt 2 Suppl 60):7-15.
Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730-737.
Hallett JW Jr, Nora JD, Hollier LH, Cherry KJ Jr, Pairolero PC. Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors. J Vasc Surg. 1988;7(2):284-291.
Suarez C, Rodrigo JP, Bodeker CC, et al. Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy. Head Neck. 2013;35(8):1195-1204.
Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus. 2004;17(2):E4.
Gaynor BG, Elhammady MS, Jethanamest D, Angeli SI, Aziz-Sultan MA. Incidence of cranial nerve palsy after preoperative embolization of glomus jugulare tumors using Onyx. J Neurosurg. 2014;120(2):377-381.
Dalfino JC, Drazin D, Nair A, Gifford E, Boulos AS. Successful Onyx embolization of a giant glomus jugulare: case report and review of nonsurgical treatment options. World Neurosurg. 2014;81(5-6):842.e11-842.e16.
Young NM, Wiet RJ, Russell EJ, Monsell EM. Superselective embolization of glomus jugulare tumors. Ann Otol Rhinol Laryngol. 1988;97(6 Pt 1):613-620.
Ozyer U, Harman A, Yildirim E, Aytekin C, Akay TH, Boyvat F. Devascularization of head and neck paragangliomas by direct percutaneous embolization. Cardiovasc Intervent Radiol. 2010;33(5):967-975.
White JB, Link MJ, Cloft HJ. Endovascular embolization of paragangliomas: a safe adjuvant to treatment. J Vasc Interv Neurol. 2008;1(2):37-41.
Cao KI, Feuvret L, Herman P, et al. Protontherapy of head and neck paragangliomas: a monocentric study. Cancer Radiother. 2018;22(1):31-37.
Ivan ME, Sughrue ME, Clark AJ, et al. A meta-analysis of tumor control rates and treatmentrelated morbidity for patients with glomus jugulare tumors. J Neurosurg. 2011;114(5):1299-1305.
Lieberson RE, Adler JR, Soltys SG, Choi C, Gibbs IC, Chang SD. Stereotactic radiosurgery as the primary treatment for new and recurrent paragangliomas: is open surgical resection still the treatment of choice? World Neurosurg. 2012;77(5-6):745-761.
Shapiro S, Kellermeyer B, Ramadan J, Jones G, Wiseman B, Cassis A. Outcomes of primary radiosurgery treatment of glomus jugulare tumors: systematic review with meta-analysis. Otol Neurotol. 2018;39(9):1079-1087.
Sharma M, Meola A, Bellamkonda S, et al. Long-term outcome following stereotactic radiosurgery for glomus jugulare tumors: a single institution experience of 20 years. Neurosurgery. 2018;83(5):1007-1014.
Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER. Stereotactic radiosurgical treatment of glomus jugulare tumors. Otol Neurotol. 2017;38(4):555-562.
Sheehan JP, Tanaka S, Link MJ, et al. Gamma Knife surgery for the management of glomus tumors: a multicenter study. J Neurosurg. 2012;117(2):246-254.
Guss ZD, Batra S, Li G, et al. Radiosurgery for glomus jugulare: history and recent progress. Neurosurg Focus. 2009;27(6):E5.
Fu D, Kuduvalli G. A fast, accurate, and automatic 2D-3D image registration for image-guided cranial radiosurgery. Med Phys. 2008;35(5):2180-2194.
Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
Lim M, Gibbs IC, Adler JR Jr, Chang SD. Efficacy and safety of stereotactic radiosurgery for glomus jugulare tumors. Neurosurg Focus. 2004;17(2):E11.
Lim M, Bower R, Nangiana JS, Adler JR, Chang SD. Radiosurgery for glomus jugulare tumors. Technol Cancer Res Treat. 2007;6(5):419-423.
Tuniz F, Soltys SG, Choi CY, et al. Multisession cyberknife stereotactic radiosurgery of large, benign cranial base tumors: preliminary study. Neurosurgery. 2009;65(5):898-907.
Bianchi LC, Marchetti M, Brait L, et al. Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery. Neurol Sci. 2009;30(6):479-485.
Golanov AV, Kapitanov DN, Pronin IN, et al. First experience of CyberKnife stereotactic radiotherapy for glomus jugulare tumors. Zh Vopr Neirokhir Im N N Burdenko. 2012;76(1):30-36. discussion 6.
Hurmuz P, Cengiz M, Ozyigit G, et al. Robotic stereotactic radiosurgery in patients with unresectable glomus jugulare tumors. Technol Cancer Res Treat. 2013;12(2):109-113.
Chun SG, Nedzi LA, Choe KS, et al. A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors). Stereotact Funct Neurosurg. 2014;92(3):153-159.
Marchetti M, Pinzi V, Tramacere I, Bianchi LC, Ghielmetti F, Fariselli L. Radiosurgery for paragangliomas of the head and neck: another step for the validation of a treatment paradigm. World Neurosurg. 2017;98:281-287.
Tosun I, Atalar B, Sahin B, et al. Robotic radiosurgery of head and neck paragangliomas: a single institution experience. Asia Pac J Clin Oncol. 2018;14(2):e3-e7.
Pollock BE, Foote RL. The evolving role of stereotactic radiosurgery for patients with skull base tumors. J Neurooncol. 2004;69(1-3):199-207.
Boyle JO, Shimm DS, Coulthard SW. Radiation therapy for paragangliomas of the temporal bone. Laryngoscope. 1990;100(8):896-901.
Jansen JC, van den Berg R, Kuiper A, van der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88(12):2811-2816.
van der Mey AG, Frijns JH, Cornelisse CJ, et al. Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol. 1992;101(8):635-642.
Al-Mefty O, Teixeira A. Complex tumors of the glomus jugulare: criteria, treatment, and outcome. J Neurosurg. 2002;97(6):1356.
Manolidis S, Shohet JA, Jackson CG, Glasscock ME 3rd. Malignant glomus tumors. Laryngoscope. 1999;109(1):30-34.
Larson TC 3rd, Reese DF, Baker HL Jr, McDonald TJ. Glomus tympanicum chemodectomas: radiographic and clinical characteristics. Radiology. 1987;163(3):801-806.
Lo WW, Solti-Bohman LG, Lambert PR. High-resolution CT in the evaluation of glomus tumors of the temporal bone. Radiology. 1984;150(3):737-742.
Havekes B, van der Klaauw AA, Hoftijzer HC, et al. Reduced quality of life in patients with headand-neck paragangliomas. Eur J Endocrinol. 2008;158(2):247-253.
van Hulsteijn LT, Louisse A, Havekes B, et al. Quality of life is decreased in patients with paragangliomas. Eur J Endocrinol. 2013;168(5):689-697.
Galland-Girodet S, Maire JP, De-Mones E, et al. The role of radiation therapy in the management of head and neck paragangliomas: impact of quality of life versus treatment response. Radiother Oncol. 2014;111(3):463-467.
Patel NS, Link MJ, Tombers NM, Pollock BE, Carlson ML. Quality of life in jugular paraganglioma following radiosurgery. Otol Neurotol. 2019;40(6):820-825.
El Majdoub F, Hunsche S, Igressa A, Kocher M, Sturm V, Maarouf M. Stereotactic LINACRadiosurgery for glomus jugulare tumors: a long-term follow-up of 27 patients. PLoS One. 2015;10(6):e0129057.
Neves F, Huwart L, Jourdan G, et al. Head and neck paragangliomas: value of contrastenhanced 3D MR angiography. AJNR Am J Neuroradiol. 2008;29(5):883-889.